The current price is at a 5.6% discount to NAV, which has been closing. BME has traded at a premium to NAV for long periods ...
abrdn Healthcare Opportunities Fund's performance improved in 2024, driven by net realized gains and option income. However, net investment income levels can be improved. The fund's price no longer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback